AGC Sells Colorado Biopharmaceuticals CDMO Sites; Records ¥10.4B Loss On Sale
Share
Why It Matters
AGC sold off some drug manufacturing sites in Colorado. They took a big loss on the sale, which shows the business wasn't worth what they paid.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.